Basic peptide system for efficient delivery of foreign genes.
Certain peptides containing high percentage of cationic amino acids are known to efficiently translocate through the cell membrane. This principle was previously exploited for delivery of variety proteins. We had observed that various basic peptides of earlier studies, though not specifically use for gene delivery, contain DNA or RNA binding domains. In the present study, we reported on arginine peptides, which form DNA complexes that efficiently transfect various cell lines. The transfection abilities of the peptides were observed by green fluorescent protein (GFP) and beta-galactosidase gene expression in 293T, HeLa, Jurkat, and COS-7 cells. We found superior transfection activity of arginine peptides compared with commercially available efficient transfection agents. The expression of marker genes induced by arginine peptides was partially inhibited in the presence of heparan sulfate, chondroitin sulfate B and C, or both heparinase III and chondroitinase ABC. The transfection proficiency of these peptides was affected by endosomotropic reagent as well as low temperature (4 degrees C). Finally, we have investigated the potential of arginine peptides as a delivery agent for gene therapy, by attempting to deliver herpes simplex virus thymidine kinase (HSV-TK) gene into tumor cells. HSV-TK transfected tumor cells exhibited sensitivity to the antiviral drug ganciclovir (GCV), leading to cell death. Taken together, these data demonstrate that arginine peptide is proficient for transfection, indicating its potentially benefit to studies in gene therapy and gene delivery in a range of model organisms.
Kim
Hyun Hee
HH
CoreBiotech, 906 KITI B/D, Suwon University, Hwasung, Kyunggido 445-743, South Korea.
Lee
Woo Sung
WS
Yang
Jai Myung
JM
Shin
Sungho
S
D000818:Animals; D001120:Arginine; D001692:Biological Transport; D002460:Cell Line; D004247:DNA / Q000008:administration & dosage*; D015316:Genetic Therapy / Q000379:methods*; D006801:Humans; D009369:Neoplasms / Q000628:therapy; D010455:Peptides / Q000008:administration & dosage*; D011509:Proteoglycans / Q000502:physiology; D013937:Thymidine Kinase / Q000235:genetics; D014162:Transfection / Q000379:methods*
D010455:Peptides; D011509:Proteoglycans; D004247:DNA; D001120:Arginine; D013937:Thymidine Kinase